Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction.
Spiroski AM, McCracken IR, Thomson A, Magalhaes-Pinto M, Lalwani MK, Newton KJ, Miller E, Bénézech C, Hadoke P, Brittan M, Mountford JC, Beqqali A, Gray GA, Baker AH.
Spiroski AM, et al.
Front Cardiovasc Med. 2022 Oct 10;9:953211. doi: 10.3389/fcvm.2022.953211. eCollection 2022.
Front Cardiovasc Med. 2022.
PMID: 36299872
Free PMC article.